0.4216
price down icon1.95%   -0.0084
after-market アフターアワーズ: .42 -0.0016 -0.38%
loading
前日終値:
$0.43
開ける:
$0.42
24時間の取引高:
305.18K
Relative Volume:
0.69
時価総額:
$12.16M
収益:
$16.77M
当期純損益:
$-11.87M
株価収益率:
-0.6735
EPS:
-0.626
ネットキャッシュフロー:
$-5.90M
1週間 パフォーマンス:
-22.14%
1か月 パフォーマンス:
-32.54%
6か月 パフォーマンス:
-67.06%
1年 パフォーマンス:
-75.49%
1日の値動き範囲:
Value
$0.4005
$0.45
1週間の範囲:
Value
$0.4005
$0.53
52週間の値動き範囲:
Value
$0.4005
$2.60

Immunoprecise Antibodies Ltd Stock (IPA) Company Profile

Name
名前
Immunoprecise Antibodies Ltd
Name
セクター
Healthcare (1182)
Name
電話
-
Name
住所
-
Name
職員
101
Name
Twitter
Name
次回の収益日
2024-09-16
Name
最新のSEC提出書
Name
IPA's Discussions on Twitter

Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-12-02 開始されました H.C. Wainwright Buy
2021-10-25 開始されました The Benchmark Company Buy

Immunoprecise Antibodies Ltd (IPA) 最新ニュース

pulisher
07:39 AM

ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation - BioSpace

07:39 AM
pulisher
Oct 28, 2024

ImmunoPrecise Pummeled Despite Advancing Anti-Aging Research with Mayo - Baystreet.ca

Oct 28, 2024
pulisher
Oct 28, 2024

Immunoprecise Antibodies Ltd (IPA-Q) QuotePress Release - The Globe and Mail

Oct 28, 2024
pulisher
Oct 24, 2024

ImmunoPrecise Antibodies Announces Annual Meeting Plans - TipRanks

Oct 24, 2024
pulisher
Oct 21, 2024

ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024 - BioSpace

Oct 21, 2024
pulisher
Oct 21, 2024

ImmunoPrecise touts potential of rabbit monoclonal antibodies in oncology - Pharmaceutical Technology

Oct 21, 2024
pulisher
Oct 21, 2024

ImmunoPrecise Antibodies to Join AI Drug Summit - TipRanks

Oct 21, 2024
pulisher
Oct 11, 2024

ImmunoPrecise Sets Virtual AGM for November 2024 - TipRanks

Oct 11, 2024
pulisher
Oct 10, 2024

ImmunoPrecise Heralds Nobel Win, AI-Driven Biotherapeutics - TipRanks

Oct 10, 2024
pulisher
Oct 10, 2024

ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design - Business Wire

Oct 10, 2024
pulisher
Oct 09, 2024

ImmunoPrecise Antibodies Ltd (IPA) Q4 2024 Earnings Call Highlights: Record Revenue Growth Amid ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 07, 2024

Financial Metrics Exploration: Understanding ImmunoPrecise Antibodies Ltd (IPA) Through Ratios - The Dwinnex

Oct 07, 2024
pulisher
Oct 07, 2024

ImmunoPrecise Antibodies Ltd (IPA) Stock: A Year of Market Fluctuations - The InvestChronicle

Oct 07, 2024
pulisher
Oct 03, 2024

Take off with ImmunoPrecise Antibodies Ltd (IPA): Get ready for trading - SETE News

Oct 03, 2024
pulisher
Oct 03, 2024

ImmunoPrecise and Biotheus partner on bispecific antibodies to treat cancer - Yahoo Finance

Oct 03, 2024
pulisher
Oct 02, 2024

ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus - BioSpace

Oct 02, 2024
pulisher
Oct 02, 2024

ImmunoPrecise Advances Cancer Therapy with Biotheus Partnership - TipRanks

Oct 02, 2024
pulisher
Oct 01, 2024

Have you been able to find a good deal on ImmunoPrecise Antibodies Ltd’s shares? - US Post News

Oct 01, 2024
pulisher
Oct 01, 2024

ImmunoPrecise Antibodies Ltd (IPA)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Oct 01, 2024
pulisher
Sep 26, 2024

ImmunoPrecise’s Breakthroughs in Cancer Antibody Therapies - TipRanks

Sep 26, 2024
pulisher
Sep 26, 2024

ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments - StockTitan

Sep 26, 2024
pulisher
Sep 23, 2024

ImmunoPrecise Sets Virtual Annual General Meeting - TipRanks

Sep 23, 2024
pulisher
Sep 23, 2024

Ratio Review: Analyzing ImmunoPrecise Antibodies Ltd (IPA)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Was ImmunoPrecise Antibodies Ltd (IPA)’s session last reading good? - US Post News

Sep 23, 2024
pulisher
Sep 18, 2024

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2025 Earnings Call Transcript - Insider Monkey

Sep 18, 2024
pulisher
Sep 18, 2024

ImmunoPrecise Unveils Executive Compensation Strategy - TipRanks

Sep 18, 2024
pulisher
Sep 17, 2024

IPA Stock Update: ImmunoPrecise Antibodies Ltd’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle

Sep 17, 2024
pulisher
Sep 17, 2024

Earnings call: ImmunoPrecise announces mixed Q1 results, eyes future growth - Investing.com Australia

Sep 17, 2024
pulisher
Sep 17, 2024

Post-Trade Analysis: ImmunoPrecise Antibodies Ltd (IPA) Slides -19.12, Closing at 0.54 - The Dwinnex

Sep 17, 2024
pulisher
Sep 17, 2024

ImmunoPrecise Antibodies Ltd (IPA) Q1 2025 Earnings Call Transcript Highlights: Revenue Growth ... - Yahoo Finance UK

Sep 17, 2024
pulisher
Sep 17, 2024

ImmunoPrecise Antibodies Ltd (IPA) Q1 2025 Earnings Call Transcript Highlights: Revenue Growth ... By GuruFocus - Investing.com Canada

Sep 17, 2024
pulisher
Sep 16, 2024

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q1 Loss, Misses Revenue Estimates - MSN

Sep 16, 2024
pulisher
Sep 16, 2024

ImmunoPrecise Achieves AI-Driven Growth Amidst Challenges - TipRanks

Sep 16, 2024
pulisher
Sep 16, 2024

ImmunoPrecise Advances Biotherapeutic Research Efficiency - TipRanks

Sep 16, 2024
pulisher
Sep 16, 2024

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 - Business Wire

Sep 16, 2024
pulisher
Sep 13, 2024

Earnings To Watch: ImmunoPrecise Antibodies Ltd (IPA) Reports Q1 2025 Result - GuruFocus.com

Sep 13, 2024
pulisher
Sep 09, 2024

ImmunoPrecise Announces Upcoming Earnings Call - TipRanks

Sep 09, 2024
pulisher
Sep 09, 2024

IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024 - Business Wire

Sep 09, 2024
pulisher
Aug 26, 2024

ImmunoPrecise Joins Prestigious Global Investment Conference - TipRanks

Aug 26, 2024
pulisher
Aug 26, 2024

ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York - Business Wire

Aug 26, 2024
pulisher
Aug 23, 2024

ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements - StockTitan

Aug 23, 2024
pulisher
Aug 19, 2024

ImmunoPrecise Antibodies Successfully Engineers in silico Antibodies to Elusive Tumor Protein Using Its Patented LENSai Technology - Chronicle-Tribune

Aug 19, 2024
pulisher
Aug 17, 2024

Short Interest in ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Declines By 14.4% - Defense World

Aug 17, 2024
pulisher
Aug 16, 2024

Benchmark Lowers ImmunoPrecise Antibodies (NASDAQ:IPA) Price Target to $3.00 - Defense World

Aug 16, 2024
pulisher
Aug 14, 2024

Immunoprecise shares target cut, rating held on market volatility - Investing.com

Aug 14, 2024
pulisher
Aug 14, 2024

Immunoprecise shares target cut, rating held on market volatility By Investing.com - Investing.com Australia

Aug 14, 2024
pulisher
Aug 10, 2024

ImmunoPrecise Antibodies (STU:TQB) Forward Dividend Yield % : 0.00% (As of Aug. 16, 2024) - GuruFocus.com

Aug 10, 2024
pulisher
Aug 01, 2024

Q1 2025 EPS Estimates for ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Cut by HC Wainwright - Defense World

Aug 01, 2024
pulisher
Jul 31, 2024

Equities Analysts Set Expectations for ImmunoPrecise Antibodies Ltd.’s FY2029 Earnings (NASDAQ:IPA) - Defense World

Jul 31, 2024

Immunoprecise Antibodies Ltd (IPA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):